StockNews.AI
SNES
StockNews.AI
6 hrs

SenesTech to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025

1. SenesTech will present at the Lytham Partners 2025 Investor Summit. 2. The webcast is scheduled for August 19, 2025, at 3:30 p.m. ET. 3. SenesTech is pioneering sustainable rodent fertility control solutions. 4. Their product ContraPest is the first EPA-registered rodent contraceptive. 5. SenesTech aims to lead the future of pest management.

9m saved
Insight
Article

FAQ

Why Bullish?

Participation in investor summits often leads to increased investor interest. Historical instances show stocks often gain traction through increased visibility and engagement with potential investors.

How important is it?

The announcement of an investor presentation increases company visibility and generates potential investor interest. This is crucial for SenesTech given its innovative approach in a niche market.

Why Short Term?

The upcoming webcast might generate immediate interest among investors. Similar events previously resulted in short-term stock price movements for other companies in tech and consumer sectors.

Related Companies

SURPRISE, Ariz., Aug. 18, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast presentation at the Lytham Partners 2025 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 19, 2025.

The webcast will take place at 3:30 p.m. ET on Tuesday, August 19, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/cts2025/ or directly at https://lythampartners.com/cts2025/snes. A replay will also be available through the same links.

About SenesTech

As the pioneers of fertility control for rodents, SenesTech's solutions are designed to integrate into any IPM program, delivering a powerful, sustainable alternative to traditional methods. We developed ContraPest®, the first and only U.S. EPA-registered contraceptive for male and female rats, and Evolve Rat and Evolve Mouse Birth Control, FIFRA 25(b) minimum-risk solutions for effective, long-term, and humane rodent population control.

Our mission is bold: healthier cities, safer environments, and smarter pest management—without compromise. We believe the future of pest control is reproductive control—and we're leading the way.

For more information, visit https://senestech.com.

Safe Harbor Statement 

This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; our ability to regain and maintain compliance with Nasdaq's continued listing requirements; and regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

CONTACT:

Investor: Robert Blum, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-participate-in-the-lytham-partners-2025-consumer--technology-investor-summit-on-august-19-2025-302532362.html

SOURCE SenesTech, Inc.

Related News